|
|
 | | | |
- close
- close
- close
- close
Chelsea Therapeutics International (CHTP) |
StreetInsider.com
May 1
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Chelsea+Therapeutics+International+Ltd.+%28CHTP%29+Posts+Q1+Loss+of+6cShare/8295741.html for the full story.
StreetInsider.com
Mar 27
Comment
UTStarcom Holdings (Nasdaq: UTSI) 23% HIGHER; holder Shah Capital Management is offering to acquire the company for $3.20 per Ordinary Share.
Image Sensing Systems, Inc. (NASDAQ: ISNS) 20% LOWER; reported Q4 EPS of $0.03, $0.17 worse than the...
StreetInsider.com
Mar 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Chelsea+Therapeutics+International+Ltd.+%28CHTP%29+Tops+Q4+EPS+by+5c/8167510.html for the full story.
Stock Blog Hub
Mar 1
Comment
Chelsea Therapeutics International Ltd. (CHTP) recently announced that it received written guidance from the Director of the Office of New Drugs at the US Food and Drug Administration (FDA) regarding the resubmission of the New Drug Application...
StreetInsider.com
Feb 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/UPDATE%3A+Needham+%26+Company+Upgrades+Chelsea+Therapeutics+%28CHTP%29+to+Buy/8116231.html for the full story.
Benzinga
Feb 20
Comment
In a report published Wednesday, Wedbush reiterated its Outperform rating on Chelsea Therapeutics International (NASDAQ: CHTP), and raised its price target from $5.00 to $7.00.
Wedbush noted, “Chelsea's apparently successful appeal to the...
StreetInsider.com
Feb 20
Comment
Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) 103.8% HIGHER; announced that it has received written guidance from the Director of the Office of New Drugs at the U.S. Food and Drug Administration (FDA) stating that Study 306B has the...
FierceBiotech
Feb 20
Comment
Interim CEO Joseph G. Oliveto
Last summer Chelsea Therapeutics ($CHTP) did some painful belt tightening after its stock price plunged following the FDA's decision to reject its application for Northera (droxidopa), saying the biotech...
StreetInsider.com
Feb 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Chelsea+Therapeutics+%28CHTP%29+Receives+FDA+Guidance+for+Northera+NDA+Resubmission/8114246.html for the full story.
Benzinga
Dec 5
Comment
Chelsea Therapeutics International (NASDAQ: CHTP) shares dipped 29.07% to $1.2710 at 9:54 am. Chelsea Therapeutics' trailing-twelve-month ROE is -114.86%.
Mattress Firm Holding (NASDAQ: MFRM) shares lost 22.82% to $23.40. Mattress Firm lowered...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
